National Cancer Institute
A new study finds that Merck’s Gardasil may provide additional protection not included in its official FDA label.
Bavarian Nordic and Bristol-Myers Squibb kicked off their latest cancer vaccine combo trial as part of a collaboration potentially worth $1 billion.
To help improve the understanding of the immune system, as well as the therapies being developed to manipulate it, the National Institutes of Health is funding a major study in pet dogs that have naturally occurring tumors.
The past few years have seen huge advances in the field of immuno-oncology, and now the NCI is funding studies in dogs that could bring those advances to veterinary medicine.